SKI Market

Indian Indices

Nifty

26,175.75 -27.20
(-0.10%)

Sensex

85,275.65 -366.25
( -0.43%)

Bank Nifty

59,681.35 -71.35
( -0.12%)

Nifty IT

37,549.75 144.25
( 0.39%)

Global Indices

Nasdaq

47,322.89 -414.54
(-0.87%)

Dow Jones

6,835.10 -34.99
(-0.51%)

Hang Seng

49,313.21 -940.70
(-1.87%)

Nikkei 225

9,706.88 -13.63
(-0.14%)

Forex

USD-INR

89.34 0.04
(0.05%)

EUR-INR

103.59 0.05
(0.05%)

GBP-INR

118.16 -0.07
(-0.06%)

JPY-INR

0.57 0.00
(0.06%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jenburkt Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524731

INE354A01013

414.3867401

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

15.34

506.05

EPS(TTM)

Face Value()

Div & Yield %

74.77

1.57

Back

AG Ventures reports consolidated net profit of Rs 0.20 crore in the September 2025 quarter

Nov 13,2025

Net profit of AG Ventures remain constant at Rs 0.20 crore in the quarter ended September 2025 and also during the previous quarter ended September 2024. Sales declined 6.73% to Rs 29.95 crore in the quarter ended September 2025 as against Rs 32.11 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	29.95	32.11	-7
OPM %	5.24	15.66	-
PBDT	2.33	5.66	-59
PBT	1.27	4.70	-73
NP	0.20	0.20	0

26,175.75 -27.20 (-0.10%)

85,275.65 -366.25 ( -0.43%)

59,681.35 -71.35 ( -0.12%)

37,549.75 144.25 ( 0.39%)

47,322.89 -414.54 (-0.87%)

6,835.10 -34.99 (-0.51%)

49,313.21 -940.70 (-1.87%)

9,706.88 -13.63 (-0.14%)

89.34 0.04 (0.05%)

103.59 0.05 (0.05%)

118.16 -0.07 (-0.06%)

0.57 0.00 (0.06%)